APLS Financials
Apellis Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$40.88
Market Cap
$5.22B
P/E Ratio
226.9
EPS
$0.18
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$781.37M
Gross Profit
-
Operating Income
-
Net Income
$-197.88M
EPS (Diluted)
$-1.60
Balance Sheet Highlights
Total Assets
$885.05M
Total Liabilities
$656.51M
Shareholders Equity
-
Cash & Equivalents
$411.29M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-87.87M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
60.3%
Operating Margin
-0.3%
Net Margin
0.0%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is APLS revenue?
APLS's most recent quarterly revenue was $781.37M. Annual revenue can be calculated by summing the four most recent quarters.
Is APLS profitable?
APLS reported a loss of $197.88M in the most recent quarter. The net profit margin is 0.0%.
What is APLS market cap?
APLS has a market capitalization of $5.22B, making it a mid-cap stock.
Does APLS have debt?
View APLS's balance sheet for debt information.
What is APLS cash flow?
Cash flow data is available in the full financial statements.